These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17680984)

  • 21. The self-assembly ability of the first microtubule-binding repeat from tau and its modulation by phosphorylation.
    Zhou LX; Zeng ZY; Du JT; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2006 Sep; 348(2):637-42. PubMed ID: 16889747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation.
    Rankin CA; Sun Q; Gamblin TC
    Brain Res Mol Brain Res; 2005 Jul; 138(1):84-93. PubMed ID: 15913837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NUB1 modulation of GSK3β reduces tau aggregation.
    Richet E; Pooler AM; Rodriguez T; Novoselov SS; Schmidtke G; Groettrup M; Hanger DP; Cheetham ME; van der Spuy J
    Hum Mol Genet; 2012 Dec; 21(24):5254-67. PubMed ID: 22965877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly.
    Evans DB; Rank KB; Bhattacharya K; Thomsen DR; Gurney ME; Sharma SK
    J Biol Chem; 2000 Aug; 275(32):24977-83. PubMed ID: 10818091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9.
    Li T; Paudel HK
    Neurosci Lett; 2007 Mar; 414(3):203-8. PubMed ID: 17317006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
    J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
    Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
    Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2.
    Hartigan JA; Xiong WC; Johnson GV
    Biochem Biophys Res Commun; 2001 Jun; 284(2):485-9. PubMed ID: 11394906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models.
    Matthews TA; Johnson GV
    Neurosci Lett; 2005 Aug; 384(3):211-6. PubMed ID: 15963640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications.
    Deutsch SI; Rosse RB; Lakshman RM
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1369-80. PubMed ID: 16793187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association of microtubule promoting and binding activity of tau with its phosphorylation sites].
    Wang J; Wei Z; Wang Q; Grundke-Iqbal I; Iqbal K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):120-3. PubMed ID: 12903511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSK-3 inhibitors for Alzheimer's disease.
    Avila J; Hernández F
    Expert Rev Neurother; 2007 Nov; 7(11):1527-33. PubMed ID: 17997701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease.
    Liu F; Liang Z; Gong CX
    Panminerva Med; 2006 Jun; 48(2):97-108. PubMed ID: 16953147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β.
    Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ
    Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argyrophilic grain disease.
    Ferrer I; Santpere G; van Leeuwen FW
    Brain; 2008 Jun; 131(Pt 6):1416-32. PubMed ID: 18234698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
    d'Abramo C; Ricciarelli R; Pronzato MA; Davies P
    J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat.
    Du JT; Yu CH; Zhou LX; Wu WH; Lei P; Li Y; Zhao YF; Nakanishi H; Li YM
    FEBS J; 2007 Oct; 274(19):5012-20. PubMed ID: 17725643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thr175-phosphorylated tau induces pathologic fibril formation via GSK3β-mediated phosphorylation of Thr231 in vitro.
    Moszczynski AJ; Gohar M; Volkening K; Leystra-Lantz C; Strong W; Strong MJ
    Neurobiol Aging; 2015 Mar; 36(3):1590-9. PubMed ID: 25573097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.
    Li T; Paudel HK
    Biochemistry; 2006 Mar; 45(10):3125-33. PubMed ID: 16519507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.